Klaus-Peter Adlassnig elected Fellow of the American College of Medical Informatics (FACMI)

Medexter’s CEO and Scientific Head Prof. Dr. Klaus-Peter Adlassnig was recognized for his accomplishments in the field of medical informatics by being elected Fellow of the American College of Medical Informatics (ACMI), Bethesda, MD, and is now eligible to use the designation FACMI. ACMI is an honorary College of elected Medical Informatics Fellows from the United States and abroad who have made significant and sustained contributions to the field of medical informatics and who have met rigorous scholarly scrutiny by their peers. The College originated in 1984 when five pioneers decided to establish an honorific society to recognize expertise in biomedical informatics. Today, there are nearly 300 Fellows, with 10–20 new Fellows elected each year when Voting Fellows of the College judge nominees during a formal election process. On November 16, 2014, the new Fellows were inducted into ACMI at ceremonies during the AMIA 2014 Annual Symposium in Washington, D.C.. The American College of Medical Informatics’ Incantation was read to the inductees: “It has been said that the sweetest reward of a life of professional achievement is recognition by one’s peers. Each of the persons recognized this evening has, by their sustained achievements, won the respect and admiration of their peers. Each of you, through your creativity, academic rigor, and perseverance, has brought recognition and honor to the discipline of Medical Informatics. Tonight, and from this point forward in time, that recognition and that honor, in some small measure, are returned to each of you. May this celebration of your achievements inspire you to yet greater contributions to Medical Informatics, for the betterment of all humanity.”

Contact Us

Let us answer your questions or make you a customized offer.

GET IN TOUCH

Newsletter

Get our newsletter with updates on our CDS developments.

SUBSCRIBE

Microbiology Analytics with Momo

Newsletter 1 / 2018

Read Newsletter

By continuing to use this site, you consent to the use of cookies in accordance to our privacy policy.